A citation-based method for searching scientific literature

Atsushi Niida, Takanori Hasegawa, Hideki Innan, Tatsuhiro Shibata, Koshi Mimori, Satoru Miyano. PeerJ 2020
Times Cited: 4







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A progenitor cell origin of myeloid malignancies.
Hiroshi Haeno, Ross L Levine, D Gary Gilliland, Franziska Michor. Proc Natl Acad Sci U S A 2009
37
25


Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons.
Eric M Pietras, Ranjani Lakshminarasimhan, Jose-Marc Techner, Sarah Fong, Johanna Flach, Mikhail Binnewies, Emmanuelle Passegué. J Exp Med 2014
168
25

Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project.
Giovanni Barosi, Ruben Mesa, Guido Finazzi, Claire Harrison, Jean-Jacques Kiladjian, Eva Lengfelder, Mary F McMullin, Francesco Passamonti, Alessandro M Vannucchi, Carlos Besses,[...]. Blood 2013
163
25


Bone marrow and the control of immunity.
Ende Zhao, Huanbin Xu, Lin Wang, Ilona Kryczek, Ke Wu, Yu Hu, Guobin Wang, Weiping Zou. Cell Mol Immunol 2012
175
25


High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a.
Jean-Jacques Kiladjian, Bruno Cassinat, Pascal Turlure, Nathalie Cambier, Murielle Roussel, Sylvia Bellucci, Marie-Laurence Menot, Gerald Massonnet, Jean-Luc Dutel, Kamel Ghomari,[...]. Blood 2006
165
25


Vascular and neoplastic risk in a large cohort of patients with polycythemia vera.
Roberto Marchioli, Guido Finazzi, Raffaele Landolfi, Jack Kutti, Heinz Gisslinger, Carlo Patrono, Raphael Marilus, Ana Villegas, Gianni Tognoni, Tiziano Barbui. J Clin Oncol 2005
476
25

Interferons in hematopoiesis and leukemia.
Christian M Schürch, Carsten Riether, Adrian F Ochsenbein. Oncoimmunology 2013
5
25

Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a.
Alfonso Quintás-Cardama, Omar Abdel-Wahab, Taghi Manshouri, Outi Kilpivaara, Jorge Cortes, Anne-Laure Roupie, Su-Jiang Zhang, David Harris, Zeev Estrov, Hagop Kantarjian,[...]. Blood 2013
145
25

Comparative long-term effects of interferon α and hydroxyurea on human hematopoietic progenitor cells.
Katherine Y King, Katie A Matatall, Ching-Chieh Shen, Margaret A Goodell, Sabina I Swierczek, Josef T Prchal. Exp Hematol 2015
26
25

The three Es of cancer immunoediting.
Gavin P Dunn, Lloyd J Old, Robert D Schreiber. Annu Rev Immunol 2004
25

Data-driven analysis of JAK2V617F kinetics during interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms.
Rasmus K Pedersen, Morten Andersen, Trine A Knudsen, Zamra Sajid, Johanne Gudmand-Hoeyer, Marc J B Dam, Vibe Skov, Lasse Kjaer, Christina Ellervik, Thomas S Larsen,[...]. Cancer Med 2020
13
25

How common are myeloproliferative neoplasms? A systematic review and meta-analysis.
Glen J Titmarsh, Andrew S Duncombe, Mary Frances McMullin, Michael O'Rorke, Ruben Mesa, Frank De Vocht, Sarah Horan, Lin Fritschi, Mike Clarke, Lesley A Anderson. Am J Hematol 2014
107
25

The myeloproliferative disorders.
Peter J Campbell, Anthony R Green. N Engl J Med 2006
442
25

Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development.
Morten Andersen, Zamra Sajid, Rasmus K Pedersen, Johanne Gudmand-Hoeyer, Christina Ellervik, Vibe Skov, Lasse Kjær, Niels Pallisgaard, Torben A Kruse, Mads Thomassen,[...]. PLoS One 2017
26
25

Mathematical analysis of the Cancitis model and the role of inflammation in blood cancer progression.
Zamra Sajid, Morten Andersen, Johnny T Ottesen. Math Biosci Eng 2019
2
50


Hematopoiesis: an evolving paradigm for stem cell biology.
Stuart H Orkin, Leonard I Zon. Cell 2008
25

Myeloproliferative neoplasms: trends in incidence, prevalence and survival in Norway.
Christina Roaldsnes, René Holst, Henrik Frederiksen, Waleed Ghanima. Eur J Haematol 2017
26
25


Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells.
Min Tang, Mithat Gonen, Alfonso Quintas-Cardama, Jorge Cortes, Hagop Kantarjian, Chani Field, Timothy P Hughes, Susan Branford, Franziska Michor. Blood 2011
48
25

Successful therapy must eradicate cancer stem cells.
David Dingli, Franziska Michor. Stem Cells 2006
150
25

Global dynamics of healthy and cancer cells competing in the hematopoietic system.
Morten Andersen, Hans C Hasselbalch, Lasse Kjær, Vibe Skov, Johnny T Ottesen. Math Biosci 2020
3
33

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.
Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Viktor Rossiev, Petr Dulicek, Arpad Illes, Halyna Pylypenko,[...]. Lancet Haematol 2020
122
25

Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report.
Ayalew Tefferi, Francisco Cervantes, Ruben Mesa, Francesco Passamonti, Srdan Verstovsek, Alessandro M Vannucchi, Jason Gotlib, Brigitte Dupriez, Animesh Pardanani, Claire Harrison,[...]. Blood 2013
228
25

Pharmacodynamics of peginterferon alpha-2a and peginterferon alpha-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled study.
R Bruno, P Sacchi, C Scagnolari, F Torriani, L Maiocchi, S Patruno, F Bellomi, G Filice, G Antonelli. Aliment Pharmacol Ther 2007
33
25

Epidemiology of MPN: what do we know?
L A Anderson, M F McMullin. Curr Hematol Malig Rep 2014
23
25

Determining the role of inflammation in the selection of JAK2 mutant cells in myeloproliferative neoplasms.
Jie Zhang, Angela G Fleischman, Dominik Wodarz, Natalia L Komarova. J Theor Biol 2017
8
25

The mathematics of cancer: integrating quantitative models.
Philipp M Altrock, Lin L Liu, Franziska Michor. Nat Rev Cancer 2015
247
25

Bridging blood cancers and inflammation: The reduced Cancitis model.
Johnny T Ottesen, Rasmus K Pedersen, Zamra Sajid, Johanne Gudmand-Hoeyer, Katrine O Bangsgaard, Vibe Skov, Lasse Kjær, Trine A Knudsen, Niels Pallisgaard, Hans C Hasselbalch,[...]. J Theor Biol 2019
5
25

Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera.
Ann Mullally, Claudia Bruedigam, Luke Poveromo, Florian H Heidel, Amy Purdon, Therese Vu, Rebecca Austin, Dirk Heckl, Lawrence J Breyfogle, Catherine Paine Kuhn,[...]. Blood 2013
113
25

Myeloproliferative neoplasm stem cells.
Adam J Mead, Ann Mullally. Blood 2017
87
25

Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial.
Lucia Masarova, Keyur P Patel, Kate J Newberry, Jorge Cortes, Gautam Borthakur, Marina Konopleva, Zeev Estrov, Hagop Kantarjian, Srdan Verstovsek. Lancet Haematol 2017
77
25

Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
Magnus Björkholm, Asa R Derolf, Malin Hultcrantz, Sigurdur Y Kristinsson, Charlotta Ekstrand, Lynn R Goldin, Björn Andreasson, Gunnar Birgegård, Olle Linder, Claes Malm,[...]. J Clin Oncol 2011
167
25


Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.
H Vaziri, W Dragowska, R C Allsopp, T E Thomas, C B Harley, P M Lansdorp. Proc Natl Acad Sci U S A 1994
931
25

Dynamics of chronic myeloid leukaemia.
Franziska Michor, Timothy P Hughes, Yoh Iwasa, Susan Branford, Neil P Shah, Charles L Sawyers, Martin A Nowak. Nature 2005
547
25

Punctuated evolution of prostate cancer genomes.
Sylvan C Baca, Davide Prandi, Michael S Lawrence, Juan Miguel Mosquera, Alessandro Romanel, Yotam Drier, Kyung Park, Naoki Kitabayashi, Theresa Y MacDonald, Mahmoud Ghandi,[...]. Cell 2013
814
25

A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer.
Tomoko Saito, Atsushi Niida, Ryutaro Uchi, Hidenari Hirata, Hisateru Komatsu, Shotaro Sakimura, Shuto Hayashi, Sho Nambara, Yosuke Kuroda, Shuhei Ito,[...]. Nat Commun 2018
54
25

Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.
Kroopa Joshi, Marc Robert de Massy, Mazlina Ismail, James L Reading, Imran Uddin, Annemarie Woolston, Emine Hatipoglu, Theres Oakes, Rachel Rosenthal, Thomas Peacock,[...]. Nat Med 2019
88
25

Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
Marco Gerlinger, Andrew J Rowan, Stuart Horswell, M Math, James Larkin, David Endesfelder, Eva Gronroos, Pierre Martinez, Nicholas Matthews, Aengus Stewart,[...]. N Engl J Med 2012
25

Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial.
Khurum H Khan, David Cunningham, Benjamin Werner, Georgios Vlachogiannis, Inmaculada Spiteri, Timon Heide, Javier Fernandez Mateos, Alexandra Vatsiou, Andrea Lampis, Mahnaz Darvish Damavandi,[...]. Cancer Discov 2018
132
25

Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer.
Marlon Perera, Matthew J Roberts, Laurence Klotz, Celestia S Higano, Nathan Papa, Shomik Sengupta, Damien Bolton, Nathan Lawrentschuk. Nat Rev Urol 2020
16
25

Spatially resolved transcriptomics and its applications in cancer.
Silas Maniatis, Joana Petrescu, Hemali Phatnani. Curr Opin Genet Dev 2021
32
25

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing.
Marco Gerlinger, Stuart Horswell, James Larkin, Andrew J Rowan, Max P Salm, Ignacio Varela, Rosalie Fisher, Nicholas McGranahan, Nicholas Matthews, Claudio R Santos,[...]. Nat Genet 2014
859
25

Origins of lymphatic and distant metastases in human colorectal cancer.
Kamila Naxerova, Johannes G Reiter, Elena Brachtel, Jochen K Lennerz, Marc van de Wetering, Andrew Rowan, Tianxi Cai, Hans Clevers, Charles Swanton, Martin A Nowak,[...]. Science 2017
254
25

Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer.
Pedro M Enriquez-Navas, Yoonseok Kam, Tuhin Das, Sabrina Hassan, Ariosto Silva, Parastou Foroutan, Epifanio Ruiz, Gary Martinez, Susan Minton, Robert J Gillies,[...]. Sci Transl Med 2016
177
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.